A p53-dependent promoter associated with polymorphic tandem repeats controls the expression of a viral transcript encoding clustered microRNAs

RNA

Volumn 16, Issue 11, 2010, Pages 2263-2276

  Stik, Grégoire ^a   Laurent, Sylvie ^a,b   Coupeau, Damien ^a   Coutaud, Baptiste ^a   Dambrine, Ginette ^a,b   Rasschaert, Denis ^a   Muylkens, Benoît ^a,c  

^a UNIVERSITÉ DE TOURS   (France)

^b CEMAGREF   (France)

^c UNIVERSITY OF NAMUR   (Belgium)

Author keywords

Herpesvirus; MicroRNA; p53; Promoter

Indexed keywords

MICRORNA; PROTEIN P53;

3' UNTRANSLATED REGION; ARTICLE; BASE PAIRING; CELL CYCLE REGULATION; FOWL; GENE CLUSTER; GENE EXPRESSION REGULATION; GENE MAPPING; GENE SEQUENCE; HERPES VIRUS; MARDIVIRUS; MULTIGENE FAMILY; MUTAGENESIS; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN INDUCTION; TANDEM REPEAT; TRANSACTIVATION; TRANSCRIPTION INITIATION SITE; TUMOR VIRUS; VIRUS STRAIN;

ANIMALS; CELL LINE; CHICKENS; GENE EXPRESSION REGULATION, VIRAL; HERPESVIRUS 2, GALLID; HUMANS; MICRORNAS; MOLECULAR SEQUENCE DATA; MULTIGENE FAMILY; POLYMORPHISM, GENETIC; PROMOTER REGIONS, GENETIC; PROTEIN BINDING; TANDEM REPEAT SEQUENCES; TRANSCRIPTION, GENETIC; TUMOR SUPPRESSOR PROTEIN P53; VIRULENCE;

AVES; GALLID HERPESVIRUS 2; HERPESVIRIDAE;

EID: 78149304007     PISSN: 13558382     EISSN: 14699001     Source Type: Journal    
DOI: 10.1261/rna.2121210     Document Type: Article

References (61)

1. Akiyama Y, Kato S, Iwa N. 1973. Continuous cell culture from lymphoma of Marek's disease. Biken J 16: 177-179.
2. Ambros V. 2004. The functions of animal microRNAs. Nature 431: 350-355.
3. Ason B, Darnell DK, Wittbrodt B, Berezikov E, Kloosterman WP, Wittbrodt J, Antin PB, Plasterk RH. 2006. Differences in vertebrate microRNA expression. Proc Natl Acad Sci 103: 14385-14389.
4. Bartel DP. 2004. MicroRNAs: Genomics, biogenesis, mechanism, and function. Cell 116: 281-297.
5. Birney E, Stamatoyannopoulos JA, Dutta A, Guigo R, Gingeras TR, Margulies EH, Weng Z, Snyder M, Dermitzakis ET, Thurman RE, et al. 2007. Identification and analysis of functional elements in 1% of the human genome by the ENCODE pilot project. Nature 447: 799-816. (Pubitemid 46920138)
6. Brennecke J, Hipfner DR, Stark A, Russell RB, Cohen SM. 2003. bantam encodes a developmentally regulated microRNA that controls cell proliferation and regulates the proapoptotic gene hid in Drosophila. Cell 113: 25-36.
7. Burgess SC, Young JR, Baaten BJ, Hunt L, Ross LN, Parcells MS, Kumar PM, Tregaskes CA, Lee LF, Davison TF. 2004. Marek's disease is a natural model for lymphomas overexpressing Hodgkin's disease antigen (CD30). Proc Natl Acad Sci 101: 13879-13884.
8. Burnside J, Morgan RW. 2007. Genomics and Marek's disease virus. Cytogenet Genome Res 117: 376-387.
9. Burnside J, Bernberg E, Anderson A, Lu C, Meyers BC, Green PJ, Jain N, Isaacs G, Morgan RW. 2006. Marek's disease virus encodes microRNAs that map to meq and the latency-associated transcript. J Virol 80: 8778-8786.
10. Burnside J, Ouyang M, Anderson A, Bernberg E, Lu C, Meyers BC, Green PJ, Markis M, Isaacs G, Huang E, et al. 2008. Deep sequencing of chicken microRNAs. BMC Genomics 9: 185. doi: 10.1186/1471-2164-9-185.
11. Cantello JL, Anderson AS, Morgan RW. 1994. Identification of latency-associated transcripts that map antisense to the ICP4 homolog gene of Marek's disease virus. J Virol 68: 6280-6290. (Pubitemid 24294878)
12. Cantello JL, Parcells MS, Anderson AS, Morgan RW. 1997. Marek's disease virus latency-associated transcripts belong to a family of spliced RNAs that are antisense to the ICP4 homolog gene. J Virol 71: 1353-1361.
13. Carninci P. 2008. Non-coding RNA transcription: Turning on neighbours. Nat Cell Biol 10: 1023-1024.
14. Carninci P, Sandelin A, Lenhard B, Katayama S, Shimokawa K, Ponjavic J, Semple CA, Taylor MS, Engstrom PG, Frith MC, et al. 2006. Genome-wide analysis of mammalian promoter architecture and evolution. Nat Genet 38: 626-635.
15. Chang TC, Wentzel EA, Kent OA, Ramachandran K, Mullendore M, Lee KH, Feldmann G, Yamakuchi M, Ferlito M, Lowenstein CJ, et al. 2007. Transactivation of miR-34a by p53 broadly influences gene expression and promotes apoptosis. Mol Cell 26: 745-752.
16. Chang TC, Yu D, Lee YS, Wentzel EA, Arking DE, West KM, Dang CV, Thomas-Tikhonenko A, Mendell JT. 2008. Widespread microRNA repression by Myc contributes to tumorigenesis. Nat Genet 40: 43-50.
17. Deng W, Roberts SG. 2005. A core promoter element downstream of the TATA box that is recognized by TFIIB. Genes Dev 19: 2418-2423.
18. el-Deiry WS, Kern SE, Pietenpol JA, Kinzler KW, Vogelstein B. 1992. Definition of a consensus binding site for p53. Nat Genet 1: 45-49.
19. Espinosa JM, Emerson BM. 2001. Transcriptional regulation by p53 through intrinsic DNA/chromatin binding and site-directed co-factor recruitment. Mol Cell 8: 57-69.
20. Frith MC, Valen E, Krogh A, Hayashizaki Y, Carninci P, Sandelin A. 2008. A code for transcription initiation in mammalian genomes. Genome Res 18: 1-12.
21. Gimeno IM, Witter RL, Fadly AM, Silva RF. 2005. Novel criteria for the diagnosis of Marek's disease virus-induced lymphomas. Avian Pathol 34: 332-340.
22. Harris SL, Levine AJ. 2005. The p53 pathway: Positive and negative feedback loops. Oncogene 24: 2899-2908.
23. Hirai K, Yamada M, Arao Y, Kato S, Nii S. 1990. Replicating Marek's disease virus (MDV) serotype 2 DNA with inserted MDV serotype 1 DNA sequences in a Marek's disease lymphoblastoid cell line MSB1-41C. Arch Virol 114: 153-165.
24. Hwang BJ, Ford JM, Hanawalt PC, Chu G. 1999. Expression of the p48 xeroderma pigmentosum gene is p53-dependent and is involved in global genomic repair. Proc Natl Acad Sci 96: 424-428.
25. Irwin MS, Kaelin WG. 2001. p53 family update: p73 and p63 develop their own identities. Cell Growth Differ 12: 337-349.
26. Javahery R, Khachi A, Lo K, Zenzie-Gregory B, Smale ST. 1994. DNA sequence requirements for transcriptional initiator activity in mammalian cells. Mol Cell Biol 14: 116-127. (Pubitemid 24013074)
27. Ji Q, Hao X, Meng Y, Zhang M, Desano J, Fan D, Xu L. 2008. Restoration of tumor suppressor miR-34 inhibits human p53-mutant gastric cancer tumorspheres. BMC Cancer 8: 266. doi: 10.1186/1471-2407-8-266.
28. Jones C. 2003. Herpes simplex virus type 1 and bovine herpesvirus 1 latency. Clin Microbiol Rev 16: 79-95.
29. Jordan JJ, Menendez D, Inga A, Nourredine M, Bell D, Resnick MA. 2008. Noncanonical DNA motifs as transactivation targets by wild type and mutant p53. PLoS Genet 4: e1000104.doi: 10.1371/journal.pgen.1000104.
30. Landgraf P, Rusu M, Sheridan R, Sewer A, Iovino N, Aravin A, Pfeffer S, Rice A, Kamphorst AO, Landthaler M, et al. 2007. A mammalian microRNA expression atlas based on small RNA library sequencing. Cell 129: 1401-1414.
31. Lee DH, Gershenzon N, Gupta M, Ioshikhes IP, Reinberg D, Lewis BA. 2005. Functional characterization of core promoter elements: The downstream core element is recognized by TAF1. Mol Cell Biol 25: 9674-9686.
32. Morgan R, Anderson A, Bernberg E, Kamboj S, Huang E, Lagasse G, Isaacs G, Parcells M, Meyers BC, Green PJ, et al. 2008. Sequence conservation and differential expression of Marek's disease virus microRNAs. J Virol 82: 12213-12220.
33. Nakano K, Vousden KH. 2001. PUMA, a novel proapoptotic gene, is induced by p53. Mol Cell 7: 683-694.
34. Oren M. 2003. Decision making by p53: Life, death and cancer. Cell Death Differ 10: 431-442. (Pubitemid 36626355)
35. Osterrieder N, Kamil JP, Schumacher D, Tischer BK, Trapp S. 2006. Marek's disease virus: From miasma to model. Nat Rev Microbiol 4: 283-294.
36. Ozsolak F, Poling LL, Wang Z, Liu H, Liu XS, Roeder RG, Zhang X, Song JS, Fisher DE. 2008. Chromatin structure analyses identify miRNA promoters. Genes Dev 22: 3172-3183.
37. Pasquinelli AE, Hunter S, Bracht J. 2005. MicroRNAs: A developing story. Curr Opin Genet Dev 15: 200-205.
38. Petherbridge L, Howes K, Baigent SJ, Sacco MA, Evans S, Osterrieder N, Nair V. 2003. Replication-competent bacterial artificial chromosomes of Marek's disease virus: Novel tools for generation of molecularly defined herpesvirus vaccines. J Virol 77: 8712-8718.
39. Raver-Shapira N, Marciano E, Meiri E, Spector Y, Rosenfeld N, Moskovits N, Bentwich Z, Oren M. 2007. Transcriptional activation of miR-34a contributes to p53-mediated apoptosis. Mol Cell 26: 731-743.
40. Raymond CK, Roberts BS, Garrett-Engele P, Lim LP, Johnson JM. 2005. Simple, quantitative primer-extension PCR assay for direct monitoring of microRNAs and short-interfering RNAs. RNA 11: 1737-1744.
41. Resnick-Silverman L, St Clair S, Maurer M, Zhao K, Manfredi JJ. 1998. Identification of a novel class of genomic DNA-binding sites suggests a mechanism for selectivity in target gene activation by the tumor suppressor protein p53. Genes Dev 12: 2102-2107.
42. Sachdeva M, Zhu S, Wu F, Wu H, Walia V, Kumar S, Elble R, Watabe K, Mo YY. 2009. p53 represses c-Myc through induction of the tumor suppressor miR-145. Proc Natl Acad Sci U S A 106: 3207-3212.
43. Sandelin A, Carninci P, Lenhard B, Ponjavic J, Hayashizaki Y, Hume DA. 2007. Mammalian RNA polymerase II core promoters: Insights from genome-wide studies. Nat Rev Genet 8: 424-436.
44. Sato F, Kurokawa M, Yamauchi N, Hattori MA. 2006. Gene silencing of myostatin in differentiation of chicken embryonic myoblasts by small interfering RNA. Am J Physiol Cell Physiol 291: C538-C545.
45. Shkreli M, Dambrine G, Soubieux D, Kut E, Rasschaert D. 2007. Involvement of the oncoprotein c-Myc in viral telomerase RNA gene regulation during Marek's disease virus-induced lymphomagenesis. J Virol 81: 4848-4857. (Pubitemid 46668681)
46. Smale ST, Kadonaga JT. 2003. The RNA polymerase II core promoter. Annu Rev Biochem 72: 449-479.
47. Song B, Wang Y, Kudo K, Gavin EJ, Xi Y, Ju J. 2008. miR-192 regulates dihydrofolate reductase and cellular proliferation through the p53-microRNA circuit. Clin Cancer Res 14: 8080-8086.
48. Spatz SJ, Silva RF. 2007a. Polymorphisms in the repeat long regions of oncogenic and attenuated pathotypes of Marek's disease virus 1. Virus Genes 35: 41-53.
49. Spatz SJ, Silva RF. 2007b. Sequence determination of variable regions within the genomes of gallid herpesvirus-2 pathotypes. Arch Virol 152: 1665-1678.
50. Suzuki Y, Tsunoda T, Sese J, Taira H, Mizushima-Sugano J, Hata H, Ota T, Isogai T, Tanaka T, Nakamura Y, et al. 2001. Identification and characterization of the potential promoter regions of 1031 kinds of human genes. Genome Res 11: 677-684.
51. Taganov KD, Boldin MP, Chang KJ, Baltimore D. 2006. NF-κB-dependent induction of microRNA miR-146, an inhibitor targeted to signaling proteins of innate immune responses. Proc Natl Acad Sci 103: 12481-12486.
52. Tagawa H, Karube K, Tsuzuki S, Ohshima K, Seto M. 2007. Synergistic action of the microRNA-17 polycistron and Myc in aggressive cancer development. Cancer Sci 98: 1482-1490.
53. Tazawa H, Tsuchiya N, Izumiya M, Nakagama H. 2007. Tumor-suppressive miR-34a induces senescence-like growth arrest through modulation of the E2F pathway in human colon cancer cells. Proc Natl Acad Sci 104: 15472-15477.
54. Thornborrow EC, Manfredi JJ. 1999. One mechanism for cell type-specific regulation of the bax promoter by the tumor suppressor p53 is dictated by the p53 response element. J Biol Chem 274: 33747-33756.
55. Toledo F, Wahl GM. 2006. Regulating the p53 pathway: In vitro hypotheses, in vivo veritas. Nat Rev Cancer 6: 909-923.
56. Vassilev LT. 2005. p53 Activation by small molecules: Application in oncology. J Med Chem 48: 4491-4499.
57. Vousden KH, Prives C. 2005. p53 And prognosis: new insights and further complexity. Cell 120: 7-10.
58. Xu P, Vernooy SY, Guo M, Hay BA. 2003. The Drosophila microRNA Mir-14 suppresses cell death and is required for normal fat metabolism. Curr Biol 13: 790-795. (Pubitemid 36531030)
59. Xu H, Yao Y, Zhao Y, Smith LP, Baigent SJ, Nair V. 2008. Analysis of the expression profiles of Marek's disease virus-encoded micro-RNAs by real-time quantitative PCR. J Virol Methods 149: 201-208.
60. Yang C, Bolotin E, Jiang T, Sladek FM, Martinez E. 2007. Prevalence of the initiator over the TATA box in human and yeast genes and identification of DNA motifs enriched in human TATA-less core promoters. Gene 389: 52-65.
61. Yao Y, Zhao Y, Xu H, Smith LP, Lawrie CH, Watson M, Nair V. 2008. MicroRNA profile of Marek's disease virus-transformed T-cell line MSB-1: Predominance of virus-encoded microRNAs. J Virol 82: 4007-4015.